String Vessel Formation is Increased in the Brain of Parkinson Disease.

BACKGROUND String vessels are collapsed basement membrane without endothelium and have no function in circulation. String vessel formation contributes to vascular degeneration in Alzheimer disease. By comparing to age-matched control cases we have recently reported endothelial degeneration in brain capillaries of human Parkinson disease (PD). OBJECTIVE Current study evaluated changes of basement membrane of capillaries, string vessel formation and their association with astrocytes, blood-brain-barrier integrity and neuronal degeneration in PD. METHODS Brain tissue from human cases of PD and age-matched controls was used. Immunohistochemical staining for collagen IV, GFAP, NeuN, tyrosine hydroxylase, fibrinogen and Factor VIII was evaluated by image analysis in the substantia nigra, caudate nucleus and middle frontal gyrus. RESULTS While the basement-membrane-associated vessel density was similar between the two groups, the density of string vessels was significantly increased in the PD cases, particularly in the substantia nigra. Neuronal degeneration was found in all brain regions. Astrocytes and fibrinogen were increased in the caudate nuclei of PD cases compared with control cases. CONCLUSIONS Endothelial degeneration and preservation of basement membrane result in an increase of string vessel formation in PD. The data may suggest a possible role for cerebral hypoperfusion in the neuronal degeneration characteristic of PD, which needs further investigation. Elevated astrocytosis in the caudate nucleus of PD cases could be associated with disruption of the blood-brain barrier in this brain region.

[1]  H. Shill,et al.  Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects , 2012, Neurological research.

[2]  N. Narayanan,et al.  Prefrontal dopamine signaling and cognitive symptoms of Parkinson’s disease , 2013, Reviews in the neurosciences.

[3]  S. Kawamoto,et al.  Identification of Neuronal Nuclei (NeuN) as Fox-3, a New Member of the Fox-1 Gene Family of Splicing Factors* , 2009, The Journal of Biological Chemistry.

[4]  A. Guha,et al.  Expression of vascular endothelial growth factor by reactive astrocytes and associated neoangiogenesis , 2000, Brain Research.

[5]  C. Green,et al.  Vascular Degeneration in Parkinson's Disease , 2013, Brain pathology.

[6]  David R. Croucher,et al.  t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions , 2014, Brain Research.

[7]  Chiao-Chi V. Chen,et al.  Neurovascular abnormalities in humans and mice with Huntington's disease , 2013, Experimental Neurology.

[8]  Hansjürgen Bratzke,et al.  Stages in the development of Parkinson’s disease-related pathology , 2004, Cell and Tissue Research.

[9]  D. Choi,et al.  Cellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson's Disease , 2013, Mediators of inflammation.

[10]  W. Brown A review of string vessels or collapsed, empty basement membrane tubes. , 2010, Journal of Alzheimer's disease : JAD.

[11]  Amity E. Green,et al.  Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia , 2010, Movement disorders : official journal of the Movement Disorder Society.

[12]  W. Poewe Treatments for Parkinson disease—past achievements and current clinical needs , 2009, Neurology.

[13]  Andrew King,et al.  Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium , 2008, Brain pathology.

[14]  J. C. Torre Alzheimer's disease: how does it start? , 2002 .

[15]  G. Paxinos,et al.  Evidence for plasticity of the dopaminergic system in Parkinsonism , 2008, Molecular Neurobiology.

[16]  Andrew King,et al.  Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet Europe Consortium , 2009, Acta Neuropathologica.

[17]  B. H. Choi,et al.  Role of the basement membrane in neurogenesis and repair of injury in the central nervous system , 1994, Microscopy research and technique.

[18]  P. Tresco,et al.  Astrocytes specifically remove surface-adsorbed fibrinogen and locally express chondroitin sulfate proteoglycans. , 2013, Acta biomaterialia.

[19]  Y. Koyama,et al.  Regulations of astrocytic functions by endothelins: roles in the pathophysiological responses of damaged brains. , 2012, Journal of pharmacological sciences.

[20]  C. Agulhon,et al.  Recent molecular approaches to understanding astrocyte function in vivo , 2013, Front. Cell. Neurosci..

[21]  P. Yurchenco Basement membranes: cell scaffoldings and signaling platforms. , 2011, Cold Spring Harbor perspectives in biology.

[22]  Marwan N. Sabbagh,et al.  Morphological and Pathological Evolution of the Brain Microcirculation in Aging and Alzheimer’s Disease , 2012, PloS one.

[23]  H. Braak,et al.  Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.

[24]  Charles Duyckaerts,et al.  National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.

[25]  P. Carmeliet,et al.  PIGF Knockout Delays Brain Vessel Growth and Maturation upon Systemic Hypoxic Challenge , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  William J. Brunken,et al.  Laminins containing the β2 and γ3 chains regulate astrocyte migration and angiogenesis in the retina , 2013, Development.

[27]  S. P. Hunt,et al.  Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea , 1988, Neuroscience.

[28]  S. Strickland,et al.  Fibrinogen and altered hemostasis in Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.

[29]  J. Haorah,et al.  Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions , 2006, Journal of Neuroimmune Pharmacology.

[30]  J. Ryu,et al.  A leaky blood–brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer’s disease brain , 2008, Journal of cellular and molecular medicine.

[31]  R. Macdonald,et al.  Vascular aspects of neuroprotection , 2004, Neurological research.

[32]  S Minoshima,et al.  Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.

[33]  C. Iadecola Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[34]  K. Baer,et al.  Immunohistochemical staining of post-mortem adult human brain sections , 2006, Nature Protocols.

[35]  D B Calne,et al.  Compensatory mechanisms in degenerative neurologic diseases. Insights from parkinsonism. , 1991, Archives of neurology.

[36]  Andrew King,et al.  Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. , 2009, Acta neuropathologica.

[37]  T. Joh,et al.  Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease , 2006, Experimental & Molecular Medicine.

[38]  D. Oorschot,et al.  Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease. , 2010, Brain : a journal of neurology.